DTX3L and prostate carcinoma: Although a recent in vitro study showed the effect of DTX3L via STAT1 and IRF-1 in prostate cancer cells [18], in vitro studies on Dtx3l/DTX3L functions are limited to solid tumors, and in vivo studies are further limited.